Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

The goal of this observational, no-profit, spontaneous, retrospective, monocentric study is to compare surgical and oncologic outcomes in patients affected by gastric cancer before and after the institution of the Tumor Board, a multidisciplinary weekly case discussion. The main question it aims to answer is whether the Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) of patients with non-early, non-metastatic gastric cancer undergoing surgical treatment with curative intent have improved before (from January 2018 to November 2019) and after (from December 2019 onwards) the establishment of the Multidisciplinary Tumor Board (MTB) at Fondazione Policlinico Gemelli (FPG).

Eligibility criteria

Qualifiers

pathology-confirmed diagnosis of gastric adenocarcinoma

age 18 years or older

surgical candidates with curative intent

Disqualifiers

Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD)

previous EMR or ESD (salvage surgery)

histologies other than adenocarcinoma (no squamous cell carcinomas, GISTs, sarcomas, lymphomas, etc)

unsufficient staging (unclear clinical stage at diagnosis)

Trial design

Treatments tested in this trial

  • Multidisciplinary Tumor Board

Treatment groups

250 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lead sponsor

Società Italiana di Chirurgia Oncologica SICO - ESSO affiliated

Collaborator